An interventional study of Mifepristone, misoprostol in Induced Abortion, sponsored by Gynuity Health Projects. Completed at 1 site in Tunisia. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-02-19.
Sponsored by Gynuity Health Projects · Not applicable, Interventional, and Health services research
This open-label study is being conducted to determine whether national expansion of a 400 mcg of sublingual misoprostol (i.e., under the tongue) taken 24 hours following administration of mifepristone 200 mg is effective and acceptable to new abortion providers in 14 regions.
The goal of this study is to provide answers to the following four questions:
Gynuity Health Projects is the lead sponsor of 112 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Need for surgical completion for incomplete abortions or ongoing viable pregnancies at follow up visit Study day 15.
Time frame: 2 weeks after mifepristone administration
Side effects
Time frame: 48 hours
Acceptability for women
Time frame: 2 weeks
This study is completed, as verified in Feb 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Gynuity Health Projects